Skip to main content
Clinical Trials/CTRI/2023/07/055516
CTRI/2023/07/055516
Not yet recruiting
Phase 2

Comparative Clinical Study To Evaluate The Efficacy Of Brahmi Churna Capsule And Jatamansi Churna Capsule In Pre-Menstrual Syndrome.

Parul Institute Of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E35- Disorders of endocrine glands in diseases classified elsewhere
Sponsor
Parul Institute Of Ayurveda
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Parul Institute Of Ayurveda

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18 yrs to 40 yrs of age irrespective of socio economic status and in good medical health
  • 2\. Female subjects having regular menstrual cycle with cycle length of 21\-35 days.
  • 3\. Having a minimum PMTS score \>10 and VAS score \>1
  • 4\. Symptoms should appear at definite time in luteal phase of the cycle.
  • 5\. The subject should be symptomatic for a period of last 3 or more than 3 months.
  • 6\. Symptoms should not persist beyond the 5th day of menstrual cycle.
  • 7\. The subjects who are ready to follow the treatment protocol and sign the informed consent.

Exclusion Criteria

  • 1\. Women aged below 18 and above 40 years
  • 2\. Subject suffering from other acute or chronic psychiatric illness.
  • 3\. Those with symptoms existing less than 3 menstrual cycles.
  • 4\. Subjects having diabetes mellitus, hypertension, thyroid, PCOS, DUB
  • 5\. Subjects suffering from organic brain diseases.
  • 6\. Subjects under hormonal and psychiatric treatment.
  • 7\. Subjects taking oral contraceptive pills.
  • 8\. Subjects with premenstrual dysphoric disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials